
Natera’s Signatera gains FDA approval, marking a pivotal shift in cancer treatment by utilizing ctDNA testing to guide…

The FDA’s approval of Langlara as an interchangeable biosimilar to Lantus promises to impact pricing in the long-acting…

The FDA’s approval of Otarmeni marks a milestone in gene therapy, offering hope to children with OTOF hereditary…

A groundbreaking study published in JAMA Network Open reveals that older women who engage in regular strength training…

In 2026, a groundbreaking study explains why probiotics work for some but not all, offering a personalization map…

The recent ACC/AHA guideline elevates ApoB testing to a new standard in cardiovascular risk assessment, offering nuanced insights…

A recent Phase 2a trial reveals that a single DMT infusion, paired with psychological support, rapidly alleviates major…

Researchers at CHOP and the University of Pennsylvania have achieved a breakthrough in personalized medicine, successfully treating a…

Senolytics like fisetin and quercetin are transforming aging research in 2026, targeting ‘zombie cells’ to combat systemic inflammation…

Oregon State University’s groundbreaking research reveals new insights into Alzheimer’s plaque formation, challenging existing assumptions and reshaping therapeutic…